{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:02:04Z","timestamp":1790812924989,"version":"4.1.0"},"reference-count":136,"publisher":"The Company of Biologists","issue":"10","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["BT\/PR8226\/BRB\/10\/1224\/2013"],"award-info":[{"award-number":["BT\/PR8226\/BRB\/10\/1224\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["BT\/BI\/25\/063\/2012"],"award-info":[{"award-number":["BT\/BI\/25\/063\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["F.3-19 \/2018\/DRS-III(SAP-II)"],"award-info":[{"award-number":["F.3-19 \/2018\/DRS-III(SAP-II)"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["DST-SERB-EMR:EMR\/ 2017\/005381"],"award-info":[{"award-number":["DST-SERB-EMR:EMR\/ 2017\/005381"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University Grants Commission","award":["F.25-1\/2013-2014(BSR)\/ 7-164\/2007(BSR)"],"award-info":[{"award-number":["F.25-1\/2013-2014(BSR)\/ 7-164\/2007(BSR)"]}]},{"name":"Sri Sathya Sai Institute of Higher Learning"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Huntington disease (HD) is a neurodegenerative disease associated with polyglutamine expansion in the protein huntingtin (HTT). Although the length of the polyglutamine repeat correlates with age at disease onset and severity, psychological, cognitive and behavioral complications point to the existence of disease modifiers. Mitochondrial dysfunction and metabolic deregulation are both associated with the HD but, despite multi-omics characterization of patients and model systems, their mechanisms have remained elusive. Systems analysis of multi-omics data and its validation by using a yeast model could help to elucidate pathways that modulate protein aggregation. Metabolomics analysis of HD patients and of a yeast model of HD was, therefore, carried out. Our analysis showed a considerable overlap of deregulated metabolic pathways. Further, the multi-omics analysis showed deregulated pathways common in human, mice and yeast model systems, and those that are unique to them. The deregulated pathways include metabolic pathways of various amino acids, glutathione metabolism, longevity, autophagy and mitophagy. The addition of certain metabolites as well as gene knockouts targeting the deregulated metabolic and autophagy pathways in the yeast model system showed that these pathways do modulate protein aggregation. Taken together, our results showed that the modulation of deregulated pathways influences protein aggregation in HD, and has implications for progression and prognosis.<\/jats:p><jats:p>This article has an associated First Person interview with the first author of the paper.<\/jats:p>","DOI":"10.1242\/dmm.049492","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:50:06Z","timestamp":1662105006000},"source":"Crossref","is-referenced-by-count":24,"title":["Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation"],"prefix":"10.1242","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-8047","authenticated-orcid":false,"given":"Sai S.","family":"Pradhan","sequence":"first","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-5645","authenticated-orcid":false,"given":"Sai M.","family":"Thota","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-5263","authenticated-orcid":false,"given":"Saiswaroop","family":"Rajaratnam","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-5847","authenticated-orcid":false,"given":"Sai K. S.","family":"Bhagavatham","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-6233","authenticated-orcid":false,"given":"Sujith K.","family":"Pulukool","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7656-4027","authenticated-orcid":false,"given":"Sriram","family":"Rathnakumar","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-7983","authenticated-orcid":false,"given":"Kanikaram S.","family":"Phalguna","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-2242","authenticated-orcid":false,"given":"Rajesh B.","family":"Dandamudi","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 2 Department of Chemistry , , Prasanthi Nilayam, Anantapur, Andhra Pradesh 515 134 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Pargaonkar","sequence":"additional","affiliation":[{"name":"Agilent Technologies Ltd. 3 Application Division , , Bengaluru 560048 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"Joseph","sequence":"additional","affiliation":[{"name":"Agilent Technologies Ltd. 3 Application Division , , Bengaluru 560048 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Joshy","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Medical Sciences 4 Department of Neurology , , Whitefield, Bengaluru, Karnataka 560066 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-5905","authenticated-orcid":false,"given":"Venketesh","family":"Sivaramakrishnan","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai Institute of Higher Learning 1 Disease Biology Lab, Department of Biosciences , , Prasanthi Nilayam, Anantapur, Andhra Pradesh , India 515134"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2022103110314929300_DMM049492C1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2217\/17460875.2.4.403","article-title":"Role of lipids in brain injury and diseases","volume":"2","author":"Adibhatla","year":"2007","journal-title":"Future Lipidol."},{"key":"2022103110314929300_DMM049492C2","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington's disease","volume":"12","author":"Andreassen","year":"2001","journal-title":"Neuroreport"},{"key":"2022103110314929300_DMM049492C3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.1085","article-title":"Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease","volume":"50","author":"Andreassen","year":"2001","journal-title":"Ann. Neurol."},{"key":"2022103110314929300_DMM049492C4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"2022103110314929300_DMM049492C5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fcell.2019.00183","article-title":"Maximizing longevity and healthspan: multiple approaches all converging on autophagy","volume":"7","author":"Bareja","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"2022103110314929300_DMM049492C6","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"2022103110314929300_DMM049492C7","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/s41598-021-94607-5","article-title":"Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis","volume":"11","author":"Bhagavatham","year":"2021","journal-title":"Sci. Rep."},{"key":"2022103110314929300_DMM049492C8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1567-1364.2010.00693.x","article-title":"Yeasts as a model for human diseases","volume":"10","author":"Bolotin-Fukuhara","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"2022103110314929300_DMM049492C9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14728222.2019.1549231","article-title":"Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease","volume":"23","author":"Boros","year":"2019","journal-title":"Expert Opin Ther. Targets"},{"key":"2022103110314929300_DMM049492C10","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022103110314929300_DMM049492C11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial Dysfunction in Huntington's Disease","volume-title":"Polyglutamine Disorders","author":"Carmo","year":"2018"},{"key":"2022103110314929300_DMM049492C12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0022-510X(84)90138-2","article-title":"Increased alanine aminotransferase activity in the Huntington's disease putamen","volume":"66","author":"Carter","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"2022103110314929300_DMM049492C13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/genes9020108","article-title":"Glutamine synthetase: localization dictates outcome","volume":"9","author":"Castegna","year":"2018","journal-title":"Genes (Basel)"},{"key":"2022103110314929300_DMM049492C14","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1073\/pnas.182276099","article-title":"Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022103110314929300_DMM049492C15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-020-14525-4","article-title":"FMN reduces Amyloid-\u03b2 toxicity in yeast by regulating redox status and cellular metabolism","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"2022103110314929300_DMM049492C16","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/nu11122923","article-title":"The effects of calorie restriction on autophagy: role on aging intervention","volume":"11","author":"Chung","year":"2019","journal-title":"Nutrients"},{"key":"2022103110314929300_DMM049492C17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0044785","article-title":"Aggregation of PolyQ proteins is increased upon yeast aging and affected by Sir2 and Hsf1: novel quantitative biochemical and microscopic assays","volume":"7","author":"Cohen","year":"2012","journal-title":"PLoS ONE"},{"key":"2022103110314929300_DMM049492C18","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","article-title":"Glutamine: metabolism and immune function, supplementation and clinical translation","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"key":"2022103110314929300_DMM049492C19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fphys.2014.00522","article-title":"Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect","volume":"5","author":"Demetrius","year":"2015","journal-title":"Front. Physiol."},{"key":"2022103110314929300_DMM049492C20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","article-title":"Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism","volume":"258","author":"den Bogaard","year":"2011","journal-title":"J. Neurol."},{"key":"2022103110314929300_DMM049492C21","doi-asserted-by":"publisher","first-page":"104569","DOI":"10.1016\/j.nbd.2019.104569","article-title":"Antibody-based therapies for Huntington's disease: current status and future directions","volume":"132","author":"Denis","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"2022103110314929300_DMM049492C22","doi-asserted-by":"publisher","first-page":"A396","DOI":"10.1289\/ehp.112-1241997","article-title":"Metabolomics--a new exciting field within the \u201comics\u201d sciences","volume":"112","author":"Dettmer","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"2022103110314929300_DMM049492C23","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1038\/s41598-019-47582-x","article-title":"Reversibility of age-related oxidized free NADH redox states in Alzheimer's disease neurons by imposed external Cys\/CySS redox shifts","volume":"9","author":"Dong","year":"2019","journal-title":"Sci. Rep."},{"key":"2022103110314929300_DMM049492C24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-0-387-30411-3_3","article-title":"1.3 Pentose Phosphate Pathway and NADPH Metabolism","volume-title":"Handbook of Neurochemistry and Molecular Neurobiology: Brain Energetics. Integration of Molecular and Cellular Processes","author":"Dringen","year":"2007"},{"key":"2022103110314929300_DMM049492C25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00401-012-1027-z","article-title":"Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study","volume":"124","author":"Durrenberger","year":"2012","journal-title":"Acta Neuropathol."},{"key":"2022103110314929300_DMM049492C26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"2022103110314929300_DMM049492C27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-018-0518-0","article-title":"Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease","volume":"6","author":"Ehrnhoefer","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"2022103110314929300_DMM049492C132","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington's disease","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"key":"2022103110314929300_DMM049492C28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington's disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"2022103110314929300_DMM049492C29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3389\/fphys.2019.01254","article-title":"Tryptophan and kynurenine pathway metabolites in animal models of retinal and optic nerve damage: different dynamics of changes","volume":"10","author":"Fiedorowicz","year":"2019","journal-title":"Front. Physiol."},{"key":"2022103110314929300_DMM049492C30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuint.2017.02.007","article-title":"Mitophagy in neurodegeneration and aging","volume":"109","author":"Fivenson","year":"2017","journal-title":"Neurochem. Int."},{"key":"2022103110314929300_DMM049492C31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/15548627.2020.1728096","article-title":"Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease","volume":"17","author":"Franco-Iborra","year":"2021","journal-title":"Autophagy"},{"key":"2022103110314929300_DMM049492C32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium","year":"2015","journal-title":"Cell"},{"key":"2022103110314929300_DMM049492C33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG repeat not polyglutamine length determines timing of Huntington's disease onset","volume":"178","author":"Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium","year":"2019","journal-title":"Cell"},{"key":"2022103110314929300_DMM049492C34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1021\/acs.jproteome.6b00049","article-title":"Novel metabolite biomarkers of Huntington's disease as detected by high-resolution mass spectrometry","volume":"15","author":"Graham","year":"2016","journal-title":"J. Proteome Res."},{"key":"2022103110314929300_DMM049492C35","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.bbadis.2018.04.012","article-title":"Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest","volume":"1864","author":"Graham","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2022103110314929300_DMM049492C36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"2022103110314929300_DMM049492C37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.18632\/oncotarget.574","article-title":"Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth","volume":"3","author":"Guido","year":"2012","journal-title":"Oncotarget"},{"key":"2022103110314929300_DMM049492C38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/135100002125000550","article-title":"Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease","volume":"7","author":"Guillemin","year":"2002","journal-title":"Redox Rep."},{"key":"2022103110314929300_DMM049492C39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4615-0135-0_19","article-title":"Quinolinic acid in the pathogenesis of Alzheimer's disease","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"2022103110314929300_DMM049492C40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/gm80","article-title":"Huntington's disease: the case for genetic modifiers","volume":"1","author":"Gusella","year":"2009","journal-title":"Genome Med."},{"key":"2022103110314929300_DMM049492C41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington's disease: GENETIC MODIFIERS OF HD","volume":"29","author":"Gusella","year":"2014","journal-title":"Mov. Disord."},{"key":"2022103110314929300_DMM049492C42","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/s41598-019-40186-5","article-title":"Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects","volume":"9","author":"Herman","year":"2019","journal-title":"Sci. Rep."},{"key":"2022103110314929300_DMM049492C43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","article-title":"Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington's disease","volume":"7","author":"Hodges","year":"2008","journal-title":"Genes Brain Behav."},{"key":"2022103110314929300_DMM049492C44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fnmol.2018.00318","article-title":"Studying Huntington's disease in yeast: from mechanisms to pharmacological approaches","volume":"11","author":"Hofer","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"2022103110314929300_DMM049492C45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pharmthera.2006.07.001","article-title":"Lipoic acid as a novel treatment for Alzheimer's disease and related dementias","volume":"113","author":"Holmquist","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"2022103110314929300_DMM049492C46","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1074\/jbc.M706499200","article-title":"Glutamate uptake and release by astrocytes are enhanced by Clostridium botulinum C3 Protein","volume":"283","author":"H\u00f6ltje","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2022103110314929300_DMM049492C47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF03033790","article-title":"Excitotoxicity of quinolinic acid: modulation by endogenous antagonists","volume":"2","author":"Jhamandas","year":"2000","journal-title":"Neurotox. Res."},{"key":"2022103110314929300_DMM049492C48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2022103110314929300_DMM049492C49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1\u03b1, mitochondrial dysfunction and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"2022103110314929300_DMM049492C50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1021\/pr900734g","article-title":"Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice","volume":"9","author":"Joyner","year":"2010","journal-title":"J. Proteome Res."},{"key":"2022103110314929300_DMM049492C51","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2958.2009.07035.x","article-title":"The molecular mechanism of mitochondria autophagy in yeast","volume":"75","author":"Kanki","year":"2010","journal-title":"Mol. Microbiol."},{"key":"2022103110314929300_DMM049492C52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/embor.2013.114","article-title":"Casein kinase 2 is essential for mitophagy","volume":"14","author":"Kanki","year":"2013","journal-title":"EMBO Rep."},{"key":"2022103110314929300_DMM049492C53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","author":"Karpuj","year":"2002","journal-title":"Nat. Med."},{"key":"2022103110314929300_DMM049492C54","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"2022103110314929300_DMM049492C55","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","article-title":"Double setback for ASO trials in Huntington disease","volume":"20","author":"Kingwell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"2022103110314929300_DMM049492C56","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis","volume":"20","author":"Kori","year":"2016","journal-title":"OMICS: A Journal of Integrative Biology"},{"key":"2022103110314929300_DMM049492C57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"2022103110314929300_DMM049492C58","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022103110314929300_DMM049492C59","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2022103110314929300_DMM049492C60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingtons Dis."},{"key":"2022103110314929300_DMM049492C61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cmet.2019.03.003","article-title":"Watch what you (self-) eat: Autophagic mechanisms that modulate metabolism","volume":"29","author":"Lahiri","year":"2019","journal-title":"Cell Metab."},{"key":"2022103110314929300_DMM049492C62","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00259-016-3417-2","article-title":"Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease","volume":"43","author":"Liguori","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2022103110314929300_DMM049492C63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbrc.2018.05.123","article-title":"The TORC1 signaling pathway regulates respiration-induced mitophagy in yeast","volume":"502","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2022103110314929300_DMM049492C133","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington's disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosc. Lett"},{"key":"2022103110314929300_DMM049492C64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11307-007-0085-4","article-title":"Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease","volume":"9","author":"Ma","year":"2007","journal-title":"Mol. Imaging Biol."},{"key":"2022103110314929300_DMM049492C65","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"2022103110314929300_DMM049492C66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","article-title":"Is brain lactate increased in Huntington's disease?","volume":"263","author":"Martin","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"2022103110314929300_DMM049492C67","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"2022103110314929300_DMM049492C68","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","article-title":"Glutathione peroxidase activity is neuroprotective in models of Huntington's disease","volume":"45","author":"Mason","year":"2013","journal-title":"Nat. Genet."},{"key":"2022103110314929300_DMM049492C69","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","article-title":"\u201cTissue\u201d transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease","volume":"9","author":"Mastroberardino","year":"2002","journal-title":"Cell Death Differ."},{"key":"2022103110314929300_DMM049492C70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.expneurol.2013.08.007","article-title":"The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain","volume":"249","author":"Mazarei","year":"2013","journal-title":"Exp. Neurol."},{"key":"2022103110314929300_DMM049492C71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"2022103110314929300_DMM049492C72","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1021\/pr500649m","article-title":"Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances","volume":"13","author":"McQuade","year":"2014","journal-title":"J. Proteome Res."},{"key":"2022103110314929300_DMM049492C73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin Investig. Drugs"},{"key":"2022103110314929300_DMM049492C74","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1074\/jbc.AC119.011578","article-title":"Glutamine and asparagine activate mTORC1 independently of Rag GTPases","volume":"295","author":"Meng","year":"2020","journal-title":"J. Biol. Chem."},{"key":"2022103110314929300_DMM049492C75","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.200112104","article-title":"Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1","volume":"157","author":"Meriin","year":"2002","journal-title":"J. Cell Biol."},{"key":"2022103110314929300_DMM049492C76","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12918-015-0253-0","article-title":"Scope and limitations of yeast as a model organism for studying human tissue-specific pathways","volume":"9","author":"Mohammadi","year":"2015","journal-title":"BMC Syst. Biol."},{"key":"2022103110314929300_DMM049492C77","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3390\/molecules24183372","article-title":"Autophagy modulation as a treatment of amyloid diseases","volume":"24","author":"Mputhia","year":"2019","journal-title":"Molecules"},{"key":"2022103110314929300_DMM049492C78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mrdd.1022","article-title":"Juvenile onset Huntington's disease\u2014clinical and research perspectives","volume":"7","author":"Nance","year":"2001","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"2022103110314929300_DMM049492C79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/NEN.0000000000000197","article-title":"Abnormalities in the tricarboxylic acid cycle in Huntington disease and in a Huntington disease mouse model","volume":"74","author":"Naseri","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2022103110314929300_DMM049492C80","doi-asserted-by":"publisher","first-page":"e0160384","DOI":"10.1371\/journal.pone.0160384","article-title":"Novel metabolic abnormalities in the tricarboxylic acid cycle in peripheral cells from Huntington's disease patients","volume":"11","author":"Naseri","year":"2016","journal-title":"PLoS ONE"},{"key":"2022103110314929300_DMM049492C81","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbadis.2008.10.002","article-title":"Autophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection","volume":"1782","author":"Nedelsky","year":"2008","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2022103110314929300_DMM049492C82","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ceb.2009.11.005","article-title":"TOR-dependent control of autophagy: biting the hand that feeds","volume":"22","author":"Neufeld","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"2022103110314929300_DMM049492C83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","article-title":"Neuroimaging in Huntington's disease","volume":"6","author":"Niccolini","year":"2014","journal-title":"World J. Radiol."},{"key":"2022103110314929300_DMM049492C84","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.273.7.3963","article-title":"Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast","volume":"273","author":"Noda","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2022103110314929300_DMM049492C85","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","article-title":"Potential function for the Huntingtin protein as a scaffold for selective autophagy","volume":"111","author":"Ochaba","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022103110314929300_DMM049492C86","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fnmol.2019.00219","article-title":"Dichloroacetate stabilizes mitochondrial fusion dynamics in models of neurodegeneration","volume":"12","author":"O'Hara","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"2022103110314929300_DMM049492C87","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2022103110314929300_DMM049492C88","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biochi.2007.08.014","article-title":"Regulation of macroautophagy by mTOR and Beclin 1 complexes","volume":"90","author":"Pattingre","year":"2008","journal-title":"Biochimie"},{"key":"2022103110314929300_DMM049492C89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","article-title":"Impaired Redox signaling in Huntington's disease: therapeutic implications","volume":"12","author":"Paul","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"2022103110314929300_DMM049492C90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine \u03b3-lyase deficiency mediates neurodegeneration in Huntington's disease","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"key":"2022103110314929300_DMM049492C91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mito.2014.05.001","article-title":"Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease","volume":"17","author":"Petersen","year":"2014","journal-title":"Mitochondrion"},{"key":"2022103110314929300_DMM049492C92","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-021-89137-z","article-title":"Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma","volume":"11","author":"Pulukool","year":"2021","journal-title":"Sci. Rep."},{"key":"2022103110314929300_DMM049492C93","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"key":"2022103110314929300_DMM049492C94","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1021\/acs.jproteome.6b00448","article-title":"Quantitative proteomic analysis reveals similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains","volume":"15","author":"Ratovitski","year":"2016","journal-title":"J. Proteome Res."},{"key":"2022103110314929300_DMM049492C95","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"2022103110314929300_DMM049492C96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1566-2772(03)00054-9","article-title":"Excitotoxicity in Huntington disease","volume":"3","author":"Raymond","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"2022103110314929300_DMM049492C97","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission","volume":"19","author":"Reddy","year":"2014","journal-title":"Drug Discov. Today"},{"key":"2022103110314929300_DMM049492C98","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-0404.1995.tb00438.x","article-title":"Decreased plasma alanine and isoleucine in Huntington's disease","volume":"91","author":"Reilmann","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"2022103110314929300_DMM049492C99","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"2022103110314929300_DMM049492C100","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/acn3.214","article-title":"A systems-level \u201cmisunderstanding\u201d: the plasma metabolome in Huntington's disease","volume":"2","author":"Rosas","year":"2015","journal-title":"Annal. Clin. Transl. Neurol."},{"key":"2022103110314929300_DMM049492C134","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2174\/1389450111007011218","article-title":"Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench","volume":"11","author":"Rosenstock","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"2022103110314929300_DMM049492C101","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2018.00400","article-title":"The therapeutic potential of metformin in neurodegenerative diseases","volume":"9","author":"Rotermund","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2022103110314929300_DMM049492C102","doi-asserted-by":"publisher","first-page":"104950","DOI":"10.1016\/j.nbd.2020.104950","article-title":"Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region","volume":"141","author":"Sapp","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"2022103110314929300_DMM049492C103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JHD-120044","article-title":"Proteomic analysis of the human brain in huntington's disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes","volume":"2","author":"Sch\u00f6nberger","year":"2013","journal-title":"J. Huntington's Dis."},{"key":"2022103110314929300_DMM049492C135","doi-asserted-by":"publisher","DOI":"10.1093\/femsyr\/fow102","article-title":"Distinct mechanisms of mutant huntingtin toxicity in different yeast strains","volume":"17","author":"Serpionov","year":"2017","journal-title":"FEMS Yeast Research"},{"key":"2022103110314929300_DMM049492C104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/146608202760196011","article-title":"Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients","volume":"3","author":"Siciliano","year":"2002","journal-title":"Amyotroph. Lateral Scler. Other. Motor Neuron Disord."},{"key":"2022103110314929300_DMM049492C105","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of Huntington's disease reveals dysfunctional astrocyte metabolism","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep."},{"key":"2022103110314929300_DMM049492C106","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","article-title":"Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells","volume":"33","author":"Smith","year":"2018","journal-title":"Mov. Disord."},{"key":"2022103110314929300_DMM049492C107","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","article-title":"Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease","volume":"4","author":"Snell","year":"1993","journal-title":"Nat. Genet."},{"key":"2022103110314929300_DMM049492C108","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"2022103110314929300_DMM049492C109","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"2022103110314929300_DMM049492C110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5949.2008.00068.x","article-title":"Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease","volume":"15","author":"Squitieri","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"2022103110314929300_DMM049492C111","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00702-011-0676-8","article-title":"Involvement of kynurenines in Huntington's disease and stroke-induced brain damage","volume":"119","author":"Stone","year":"2012","journal-title":"J. Neural. Transm."},{"key":"2022103110314929300_DMM049492C112","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"key":"2022103110314929300_DMM049492C113","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03322-9","article-title":"Acidic pH promotes the formation of toxic fibrils from \u03b2-amyloid peptide","volume":"893","author":"Su","year":"2001","journal-title":"Brain Res."},{"key":"2022103110314929300_DMM049492C114","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1&lt;80::AID-ANA13&gt;3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"2022103110314929300_DMM049492C115","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1074\/jbc.M110.101527","article-title":"Functional gene expression profiling in yeast implicates translational dysfunction in mutant Huntingtin toxicity","volume":"286","author":"Tauber","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2022103110314929300_DMM049492C116","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4103\/0028-3886.329528","article-title":"Multimodal imaging and visual evoked potentials reveal key structural and functional features that distinguish symptomatic from presymptomatic Huntington's disease brain","volume":"69","author":"Thota","year":"2021","journal-title":"Neurol. India"},{"key":"2022103110314929300_DMM049492C117","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","article-title":"Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias","volume":"378","author":"Trottier","year":"1995","journal-title":"Nature"},{"key":"2022103110314929300_DMM049492C118","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"2022103110314929300_DMM049492C119","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/mds.21540","article-title":"Clinical correlates of mitochondrial function in Huntington's disease muscle","volume":"22","author":"Turner","year":"2007","journal-title":"Mov. Disord."},{"key":"2022103110314929300_DMM049492C120","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"2022103110314929300_DMM049492C121","doi-asserted-by":"publisher","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","article-title":"Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment","volume":"314","author":"Van Skike","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2022103110314929300_DMM049492C122","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.semcdb.2011.03.011","article-title":"Amyloid in neurodegenerative diseases: friend or foe?","volume":"22","author":"Wolfe","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"2022103110314929300_DMM049492C137","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington's disease","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"2022103110314929300_DMM049492C123","doi-asserted-by":"publisher","first-page":"e13820","DOI":"10.1371\/journal.pone.0013820","article-title":"Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins","volume":"5","author":"Xiang","year":"2010","journal-title":"PLoS ONE"},{"key":"2022103110314929300_DMM049492C124","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep."},{"key":"2022103110314929300_DMM049492C125","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jnnp.62.3.290","article-title":"Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","volume":"62","author":"Yamamoto","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2022103110314929300_DMM049492C126","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway","volume":"172","author":"Yamamoto","year":"2006","journal-title":"J. Cell Biol."},{"key":"2022103110314929300_DMM049492C127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial activation in the pathogenesis of Huntington's Disease","volume":"9","author":"Yang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"2022103110314929300_DMM049492C128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-805253-2.00004-3","article-title":"Chapter 4 - mechanism and regulation of selective mitophagy in cardiometabolic disease","volume-title":"Autophagy and Cardiometabolic Diseases","author":"Yang","year":"2018"},{"key":"2022103110314929300_DMM049492C129","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","article-title":"A mitochondria-associated oxidative stress perspective on Huntington's disease","volume":"11","author":"Zheng","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"2022103110314929300_DMM049492C130","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson's Disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2022103110314929300_DMM049492C131","doi-asserted-by":"publisher","first-page":"716859","DOI":"10.4061\/2011\/716859","article-title":"The involvement of Neuroinflammation and Kynurenine pathway in Parkinson's Disease","volume":"2011","author":"Zinger","year":"2011","journal-title":"Parkinsons Dis"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049492\/2160079\/dmm049492.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049492\/2212512\/dmm049492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049492\/2212512\/dmm049492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T03:51:36Z","timestamp":1727927496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/15\/10\/dmm049492\/278789\/Integrated-multi-omics-analysis-of-Huntington"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":136,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.049492","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"article-number":"dmm049492"}}